Experimental neuro-oncology 2: immunology(Neuro-oncology Morning Session)
Tracks
Strauss 2-3
| Tuesday, October 7, 2025 |
| 7:00 AM - 8:00 AM |
Speakers & Chairs
Prof. Roland Kälin
Principal Investigator
Johannes Kepler University Linz
Chair
Marian C. Neidert
Chair
Prof. Roland Kälin
Principal Investigator
Johannes Kepler University Linz
Glioblastoma cell-derived APLN shows differential effects on myeloid cell migration
Dr. Jenny Christine Kienzler
Attending Neurosurgeon
University Hospital Lausanne
Tumor Surface Signature Distinguishes IDH Mutant from Wildtype High Grade Glioma and Identifies Novel Targets for Immunotherapy
Dr Carolina Noronha
Consultant
Centro Hospitalar Universitario Santo Antonio
ZEB1/ZEB2 Reflect EMT-Associated Immune Evasion in Glioblastoma
Ms. Angelica Patterson
PhD Student
HOCH Health Ostschweiz
Profiling the peripheral immune response in glioblastoma patients following tumor resection
Dr Johannes Falter
Resident
University Medical Center Regensburg
Pre-operative Dexamethasone application in Glioblastoma patients leads to significant changes in the myeloid immunological compartment and affects the CXCL2/IL8-CXCR-axis
Dr Eric Freund
Resident, Research fellow
Medical University of Vienna
Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients
Dr Marius Mader
Group Leader / Resident Physician
University Medical Center Hamburg-Eppendorf
Replacement of Microglia and Tumor-Associated Macrophages in Experimental Models of Brain Malignancies
Dr Eduard Yakubov
Doctor in Training
PMU Nuremberg
Tumor-associated microglia/macrophages modulate progression of malignant glomas via xCT and angiogenic gene expression
